z-logo
open-access-imgOpen Access
Cellular pharmacokinetics and intracellular activity against Listeria monocytogenes and Staphylococcus aureus of chemically modified and nanoencapsulated gentamicin
Author(s) -
Edurne Imbuluzqueta,
Sandrine Lemaire,
Carlos Gamazo,
Emilio Cornejo Elizondo,
Nora Ventosa,
Jaume Veciana,
Françoise Van Bambeke,
Marı́a J. Blanco-Prı́eto
Publication year - 2012
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dks172
Subject(s) - intracellular , gentamicin , listeria monocytogenes , extracellular , staphylococcus aureus , microbiology and biotechnology , chemistry , cytosol , intracellular parasite , antibacterial agent , biochemistry , bacteria , biology , antibiotics , enzyme , genetics
The aim of this study was to investigate different hydrophobic gentamicin formulations [gentamicin-bis(2-ethylhexyl) sulfosuccinate (GEN-AOT), microstructured GEN-AOT (PCA GEN-AOT) and GEN-AOT-loaded poly(lactide-co-glycolide) acid (PLGA) nanoparticles (NPs)] in view of improving its therapeutic index against intracellular bacteria. The intracellular accumulation, subcellular distribution and intracellular activity of GEN-AOT and NPs in different monocytic-macrophagic cell lines were studied.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom